Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 0 | 0 | 1 |
Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 4 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
AR protein | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
progesterone receptor | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
Interferon beta | 3 | 0 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Sphingosine 1-phosphate receptor 1 | 0 | 0 | 1 | 1 |
RCG53912, isoform CRA_a | 0 | 0 | 0 | 1 |
Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
Sphingosine kinase 2 | 0 | 0 | 0 | 1 |
Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Chain A, ALPHA1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
Chain A, ALPHA1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
Chain A, Alpha-mannosidase II | 0 | 1 | 0 | 1 |
Chain A, PUTATIVE ALPHA-1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
Chain A, Putative Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Chain B, Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Chain A, PUTATIVE ALPHA-1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase family protein | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase, putative | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Glycoside hydrolase family 92 | 0 | 1 | 0 | 1 |
Glycoside hydrolase family 92 | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase, putative | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase, putative | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
Alpha-1,2-mannosidase family protein | 0 | 1 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
G | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 2 | 2 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
geminin | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
TDP1 protein | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 8 |
Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |